Human symbiont Bacteroides xylanisolvens attenuates NASH through intestinal nicotine catabolism

Chin J Nat Med. 2023 Feb;21(2):81-82. doi: 10.1016/S1875-5364(23)60387-5.
No abstract available

Keywords: Drug metabolism; Gut microbiota; Nicotine; Non-alcoholic fatty liver disease.

MeSH terms

  • Bacteroides
  • Humans
  • Nicotine*
  • Non-alcoholic Fatty Liver Disease*

Substances

  • Nicotine

Supplementary concepts

  • Bacteroides xylanisolvens